LOTTE BIOLOGICS COO Hyungduk Yoo, Ph.D. participated as a speaker at BIO KOREA 2025 on May 8!

Celebrating its 20th anniversary this year, BIO KOREA 2025 is the largest biohealth event in Korea. Held at COEX in Seoul, it featured a diverse range of programs including business partnering, exhibitions, conferences, and investment fairs.

LOTTE BIOLOGICS hosted one of the 15 open sessions, focusing on the theme 'Strategies for Stabilizing the Global Pharmaceutical Supply Chain.'

"CDMOs play a pivotal role at the heart of the global supply chain, acting as a bridge between raw material suppliers and client companies. Working in the biopharmaceutical industry, it becomes clear that each role is directly connected to patients' lives."

- Global Standard Quality
- Logistical Openness
- Multi-site Operation
- Flexible Capability

"Utilizing on these strategies, LOTTE BIOLOGICS is advancing as a global-level CDMO, focusing on reliably supplying high-quality biopharmaceuticals tailored to client needs."

If you want to learn more, contact LOTTE BIOLOGICS today!😆
https://lnkd.in/gjRJqg8Y

hashtag#LOTTEBIOLOGICS hashtag#BIOKOREA2025 hashtag#CDMO hashtag#GlobalPartnership hashtag#Biomanufacturing hashtag#SupplyChainResilience